Mirati Therapeutics, Inc. (MRTX): Price and Financial Metrics
MRTX Price/Volume Stats
| Current price | $58.70 | 52-week high | $64.41 |
| Prev. close | $58.80 | 52-week low | $27.30 |
| Day low | $58.54 | Volume | 20,994,400 |
| Day high | $58.99 | Avg. volume | 2,758,857 |
| 50-day MA | $57.69 | Dividend yield | N/A |
| 200-day MA | $45.47 | Market Cap | 4.12B |
MRTX Stock Price Chart Interactive Chart >
Mirati Therapeutics, Inc. (MRTX) Company Bio
Mirati Therapeutics develops molecularly targeted cancer treatments that are intended to inhibit tumor growth. The company was founded in 1995 and is based in San Diego, California.
MRTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 3.21% |
| 3-year | -58.35% |
| 5-year | -32.55% |
| YTD | -0.09% |
| 2023 | 29.66% |
| 2022 | -69.11% |
| 2021 | -33.21% |
| 2020 | 70.45% |
| 2019 | 203.77% |
Continue Researching MRTX
Want to see what other sources are saying about Mirati Therapeutics Inc's financials and stock price? Try the links below:Mirati Therapeutics Inc (MRTX) Stock Price | Nasdaq
Mirati Therapeutics Inc (MRTX) Stock Quote, History and News - Yahoo Finance
Mirati Therapeutics Inc (MRTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...